PET brain imaging in an Alzheimer's mouse model revealed sex- and age-dependent changes in the endocannabinoid system starting from early-stage disease, with females showing earlier cannabinoid receptor changes.
Alzheimer's researchers, neuroscientists studying the endocannabinoid system, proponents of cannabinoid-based dementia treatments
Sex-dependent endocannabinoid changes detected from early-stage Alzheimer's
What the researchers found
PET imaging revealed dynamic changes in cannabinoid receptor 1 (CB1) and MAGL enzyme availability across Alzheimer's disease progression. At 4 months (early-stage), female AD mice had lower CB1 availability while males had increased MAGL. By 12 months (late-stage), CB1 was significantly reduced in AD mice compared to controls. The pattern of changes was consistently sex-dependent throughout disease progression.
Why it matters
The endocannabinoid system is a potential therapeutic target for Alzheimer's, but this study shows its changes are complex, varying by sex, age, and disease stage. This means cannabinoid-based therapies for Alzheimer's may need to be tailored to the patient's sex and disease stage to be effective.
The numbers in context
4 months: females had lower CB1, males had increased MAGL. 8 months: MAGL reduced in AD frontal cortex, males had higher MAGL than females brain-wide. 12 months: significantly lower CB1 in AD vs controls. MAGL PET imaging responsive to JZL184 inhibitor.
How the study worked
PET-CT imaging study using two radioligands ([18F]FMPEP-d2 for CB1 and [18F]MAGL-2102 for MAGL) in a knock-in Alzheimer's mouse model at 3 ages (4, 8, and 12 months). Findings were supplemented with autoradiography, immunofluorescence, and western blots.
What this study cannot tell us
Mouse model of Alzheimer's that may not fully recapitulate human disease. PET radioligand binding reflects availability, not necessarily function. Relatively small group sizes typical of PET imaging studies. Cannot directly translate timing of mouse disease stages to human disease progression.
How to read the evidence
Preliminary evidence from a PET imaging study in an Alzheimer's mouse model, providing mechanistic insights requiring human validation.
When this study was published
2025 preclinical PET imaging study of endocannabinoid system changes in Alzheimer's.
The bigger picture
Interest in cannabinoid-based Alzheimer's treatments has grown, but this study suggests a one-size-fits-all approach may not work. The endocannabinoid system changes differently in males and females with Alzheimer's, and the therapeutic window may be narrow. PET imaging could help monitor these changes and guide treatment timing.
Questions still open
- Do sex differences in endocannabinoid system changes in AD translate to humans? Could PET imaging of the endocannabinoid system serve as an early diagnostic tool for Alzheimer's? What is the optimal timing for cannabinoid-based interventions in AD?
Common questions
How does Alzheimer's affect the brain's cannabinoid system?
Why do sex differences matter?
Read the original research
Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [18F]FMPEP-d 2 and [18F]MAGL-2102.
Theranostics, 15(8), 3368-3385
Citation
Pees, Anna; Morrone, Christopher Daniel; Tong, Junchao; Rong, Jian; Shao, Tuo; Wear, Darcy; Liang, Steven H; Yu, Wai Haung; Vasdev, Neil. (2025). Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [18F]FMPEP-d 2 and [18F]MAGL-2102.. Theranostics, 15(8), 3368-3385. https://doi.org/10.7150/thno.106592
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)